DCLK1及其致癌功能:对于癌症来说是一个有前途的治疗点
Liu Ye1, Beibei Liu1, Jingling Huang1
1Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, PR China.
Life sciences
|November 25, 2023
概括
双丁类激酶1 (DCLK1) 通过调节干细胞,DNA损伤和免疫规避来促进癌症的进展. 了解DCLK1 的理解
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 双丁类激酶1 (DCLK1) 是一种蛋白激酶,涉及癌症恶性和预后.
- DCLK1作为干细胞标记物,影响瘤发生,细胞重编程和上皮-介质细胞过渡 (EMT).
- DCLK1在DNA损伤反应 (DDR),DNA修复和瘤免疫微环境 (TIM) 的调制中发挥作用.
研究的目的:
- 为提供DCLK1与瘤恶性进展的关联的全面概述.
- 为了解决DCLK1的模两可的生物学作用,特别是其α和β形式转录之间的差异.
- 突出DCLK1作为癌症诊断和治疗的潜在治疗点.
主要方法:
- 对现有文献的审查,重点关注DCLK1在瘤干细胞中的作用.
- 对DCLK1在上皮层-介质细胞转换 (EMT) 的参与进行分析.
- 检查DCLK1在DNA损伤反应 (DDR) 和瘤微环境 (TME) 中的功能.
主要成果:
- DCLK1是一种亲瘤原因子,与癌症进展和不良预后有关.
- DCLK1调节关键过程,包括干性,EMT,DDR和免疫逃避.
- DCLK1α和β形式转录的差异导致癌症恶性,使向药物开发复杂化.
结论:
- DCLK1是瘤进展的关键调节者,也是一个有前途的治疗标.
- 需要进一步的研究来澄清DCLK1异型的独特作用,以准确的治疗策略.
- 准DCLK1有可能改善癌症诊断和治疗结果.
更多相关视频
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.4K
06:24Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
359
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:15M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K